Carter demonstrated increased BCL‐2 expression in bone marrow cells, particularly in Lin(−)Sca‐1(+)cKit(+) cells of inducible CML in mice. The gene discussed is KIT; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.